<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.02">
 <iati-activity hierarchy="1" iati-activities:version="2.02" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-903-SII-34313</iati-identifier>
  <reporting-org ref="XM-DAC-903" type="40">
   <narrative xml:lang="EN">International Finance Corporation</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Weigao II Project</narrative>
  </title>
  <description type="2">
   <narrative xml:lang="EN">1. Increase access to quality and affordable dialysis medical devices. The Project will support an established domestic medical device manufacturer to expand its manufacturing capabilities in dialysis medical device. This is expected to increase the availability and affordability of dialysis medical services.   2. Promote private sector participation in the provision of dialysis treatment. The successful implementation of the Project will demonstrate to other investors the financial viability of a private sector operated standalone dialysis center, which is expected to encourage private sector participation in this area.   3. Create skilled employment opportunities. The Project will create employment opportunities for a number of specialty healthcare positions and provide training and support to its medical staff, including for doctors training for nephrologists.  4. Benefits to the local economy and local linkages: The Project will help create demand for locally-sourced materials, services and labor, majority of which are likely to be provided by small and medium enterprises.</narrative>
  </description>
  <description type="1">
   <narrative xml:lang="EN">Shandong Weigao Group Medical Polymer Company Limited (Weigao, or the Company), a Chinese medical device company listed on the Hong Kong Stock Exchange, is planning to expand its presence in the Chinese dialysis treatment market through: (i) the expansion of its manufacturing capacity for dialyzer, tubing and related consumables; and (ii) the opening of additional Company-operated standalone dialysis centers  (together, the Project).</narrative>
  </description>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">Shandong Weigao Group Medical Polymer Co., Ltd.</narrative>
  </participating-org>
  <participating-org activity-id="XM-DAC-903-SII-34313" ref="XM-DAC-903" role="1" type="40"></participating-org>
  <activity-status code="3"></activity-status>
  <activity-date iso-date="2015-01-27" type="1"></activity-date>
  <activity-date iso-date="2015-06-19" type="2"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">International Finance Corporation</narrative>
   </organisation>
   <telephone>+12024733800</telephone>
   <email>ccspg@ifc.org</email>
   <website>www.ifc.org</website>
   <mailing-address>
    <narrative xml:lang="EN">2121 Pennsylvania Avenue, NW Washington DC 20433</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <mailing-address>
    <narrative xml:lang="EN">Phyllis Chan Head of Business Development and Investor Relations Suite 801, 8th Floor, Chinachem Century Tower 178 Gloucester Road, Wanchai Hong Kong SAR, China Tel: +852 2838 1868 Fax: +852 2838 1870  http://www.weigaogroup.com</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <mailing-address>
    <narrative xml:lang="EN">Weigao will disclose this SII locally at the following addresses:  18 Xingshan Road Weihai Torch Hi-tech Science Park Shandong Province Peoples Republic of China</narrative>
   </mailing-address>
  </contact-info>
  <recipient-country code="CN" percentage="100">
   <narrative xml:lang="EN">China</narrative>
  </recipient-country>
  <location ref="CN-China">
   <location-reach code="1"></location-reach>
   <location-id code="1453782" vocabulary="G1"></location-id>
   <name>
    <narrative xml:lang="EN">The Companys headquarter, manufacturing facilities and dialysis centers are principally located in Weihai, Shandong province.</narrative>
   </name>
   <description>
    <narrative xml:lang="EN">Location description</narrative>
   </description>
   <activity-description>
    <narrative xml:lang="EN">A description that qualifies the activity taking place at the location.</narrative>
   </activity-description>
   <administrative code="1453782" level="1" vocabulary="G1"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>35.0000000000 105.0000000000</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="1"></location-class>
   <feature-designation code="ADMF"></feature-designation>
  </location>
  <sector code="325" percentage="100" vocabulary="11" vocabulary-uri="http://www.census.gov/cgi-bin/sssd/naics/naicsrch?chart=2012">
   <narrative xml:lang="EN">G-FA - Pharmaceuticals and Medicine Manufacturing</narrative>
  </sector>
  <country-budget-items vocabulary="1">
   <budget-item code="7.2.1" percentage="100" vocabulary="1">
    <description>
     <narrative xml:lang="EN">Total: $97.67 million</narrative>
    </description>
   </budget-item>
  </country-budget-items>
  <collaboration-type code="6"></collaboration-type>
  <default-flow-type code="35"></default-flow-type>
  <default-finance-type code="411"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget type="1">
   <period-start iso-date="2015-01-27"></period-start>
   <period-end iso-date="2015-06-30"></period-end>
   <value currency="USD" value-date="2015-01-27">97670000</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2015-01-27"></transaction-date>
   <value currency="USD" value-date="2015-01-27">97670000</value>
   <receiver-org>
    <narrative xml:lang="EN">Shandong Weigao Group Medical Polymer Co., Ltd.</narrative>
   </receiver-org>
   <flow-type code="35"></flow-type>
   <finance-type code="411"></finance-type>
  </transaction>
  <document-link format="TEXT/HTML" url="https://disclosures.ifc.org/#/projectDetailSII/34313">
   <title>
    <narrative xml:lang="EN">Summary of Investment Information - Anticipated Impact Measurement &amp; Monitoring (AIMM) Assessment and Main Environmental &amp; Social Risks and Impacts of the Project</narrative>
   </title>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://disclosures.ifc.org/#/projectDetailSII/34313">
   <title>
    <narrative xml:lang="EN">Summary of Investment Information</narrative>
   </title>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
 </iati-activity>
</iati-activities>
